Iodinated contrast medium: Is there a re(n)al problem? A clinical vignette-based review, Critical Care
As we were taught, for decades, that iodinated contrast-induced acute kidney injury should be dreaded, considerable efforts were made to find out effective measures in mitigating the renal risk of iodinated contrast media. Imaging procedures were frequently either downgraded (unenhanced imaging) or deferred as clinicians felt that the renal risk pertaining to contrast administration outweighed the benefits of an enhanced imaging. However, could we have missed the point? Among the abundant literature about iodinated contrast-associated acute kidney injury, recent meaningful advances may help sort out facts from false beliefs. Hence, there is increasing evidence that the nephrotoxicity directly attributable to modern iodinated CM has been exaggerated. Failure to demonstrate a clear benefit from most of the tested prophylactic measures might be an indirect consequence. However, the toxic potential of iodinated contrast media is well established experimentally and should not be overlooked completely when making clinical decisions. We herein review these advances in disease and pathophysiologic understanding and the associated clinical crossroads through a typical case vignette in the critical care setting.
Frontiers Hypersensitivity to Gadolinium-Based Contrast Media
Categories of acute adverse reactions adapted from the ACR Manual
Frontiers Artificial intelligence in critical illness and its
Effectiveness of N‐Acetylcysteine for the Prevention of Contrast
Estrategias de protección renal en Anestesiología y Cuidados
Safe Use of Contrast Media: What the Radiologist Needs to Know
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care
JCM, Free Full-Text
Biomolecules, Free Full-Text
Creatinine level variation in patients subjected to contrast
Acute Kidney Injury After Primary Angioplasty: Is Contrast‐Induced
EPOS™
